Cart
sales@molnova.com
BIT225
CAS No. 917909-71-8
BIT225( —— )
Catalog No. M34183 CAS No. 917909-71-8
BIT225 is a human immunodeficiency virus type 1 Vpu inhibitor with antiviral activity that inhibits HIV-1 replication in bone marrow dendritic cells and inhibits ion channels formed by HIV-1 Vpu.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 85 | Get Quote |
|
| 5MG | 126 | Get Quote |
|
| 10MG | 188 | Get Quote |
|
| 25MG | 342 | Get Quote |
|
| 50MG | 569 | Get Quote |
|
| 100MG | 894 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBIT225
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIT225 is a human immunodeficiency virus type 1 Vpu inhibitor with antiviral activity that inhibits HIV-1 replication in bone marrow dendritic cells and inhibits ion channels formed by HIV-1 Vpu.
-
DescriptionBIT225 is a human immunodeficiency virus type 1 Vpu inhibitor with antiviral activity that inhibits HIV-1 replication in bone marrow dendritic cells and inhibits ion channels formed by HIV-1 Vpu.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorAntiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number917909-71-8
-
Formula Weight293.32
-
Molecular FormulaC16H15N5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC(=N)N)C=1C=CC=2C(=CC=CC2C=3C=NN(C3)C)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ulipristal
Ulipristal is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure.
-
WIN 54954
WIN 54954 is an orally available antiviral agent that inhibits Coxsackievirus and inhibits viral translation or transcription.
-
SARS-CoV-2-IN-39
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
